Experimental synthesis generated dinuclear rare-earth metal–copper complexes, indicating successful characterization methods like NMR spectroscopy and X-ray diffraction.
The reaction of [LnIII(OArP-κ2O,P)3] (1-Ln, Ln = La, Sm, Y, Yb, and ArPO– = 2,4-tBu2-6-(Ph2P)C6H2O–) with the copper(I) triflate toluene adduct yields the corresponding dinuclear rare-earth metal(III)–copper(I) complexes [LnIII(OTf)(μ-OArP-1κ1O,2κ1P)3CuI] (2-Ln, Ln = La, Sm, Y, Yb) in clean conversion. In order to explore an alternative synthetic route by starting from a mononuclear copper complex instead of a rare-earth metal complex, the mononuclear copper complex [(HOArP-κP)3CuIOTf] (3) was prepared from copper(I) triflate toluene adduct and HOArP. However, the reaction of 3 with [LnIII[N(SiMe3)2]3] (Ln = La, Y) gave the heterobimetallic complexes only in low yields, along with undesired side-products. Investigation into the exchange of the triflate in 2-Ln for different groups was explored using alkaline metal amides, alkyls, and alkoxides and was successful only for reactions with KOtBu, yielding [LnIII(OtBu)(μ-OArP-1κ1O,2κ1P)3CuI] (4-Ln, Ln = La, Sm, Y, Yb). The compounds were characterized by NMR, UV–vis, and IR spectroscopy, single-crystal X-ray diffraction, and elemental analysis. The effective magnetic moments of the paramagnetic complexes were determined via the Evans NMR method.
No takes yet. Share an insight, caveat, or question.
Fleißner et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: